Measurement of glomerular filtration rate using endogenous d-serine clearance in living kidney transplant donors and recipients. (January 2022)

• Record Type: Journal Article
• Authors: Kawamura, Masataka; Hesaka, Atsushi; Taniguchi, Ayumu; Nakazawa, Shigeaki; Abe, Toyofumi; Hirata, Makoto; Sakate, Ryuichi; Horio, Masaru; Takahara, Shiro; Nonomura, Norio; Isaka, Yoshitaka; Imamura, Ryoichi; Kimura, Tomonori
• Is Part Of: EClinicalMedicine. Volume 43(2022)
• Publication Date: 2022-01
• Subjects: d-Serine -- Glomerular filtration rate -- Kidney transplantation -- Creatinine clearance -- d-Serine clearance; GFR glomerular filtration rate -- eGFR estimated glomerular filtration rate -- mGFR measure glomerular filtration rate -- C-in clearance of inulin -- C-cre clearance of creatinine -- C-dSer clearance of d-serine -- CKD chronic kidney disease -- 2D-HPLC two-dimensional high-performance liquid chromatography -- sCre serum creatinine -- sCys serum cystatin C -- CI confidence interaval; Medicine -- Research -- Periodicals; Medical policy -- Periodicals; Clinical Medicine; Health Policy; Public Health; Medical policy; Medicine -- Research; Periodical; Electronic journals; Periodicals; 613
• DOI: 10.1016/j.eclinm.2021.101223
• Languages: English
• ISSNs: 2589-5370

Abstract

Summary: Background: Endogenous molecules that provide an unbiased and a precise evaluation of kidney function are still necessary. We explored the potential of clearance of d -serine, a rare enantiomer of serine and a biomarker of kidney function, as a measure of glomerular filtration rate (GFR). Methods: This was a cross-sectional observational study of 200 living kidney transplant donors and recipients enrolled between July 2019 and December 2020 in a single Japanese center, for whom GFR was measured by clearance of inulin (C-in). Clearance of d -serine (C-d Ser) was calculated based on blood and urine levels of d -serine, as measured by two-dimensional high-performance liquid chromatography. Analytical performance was assessed by calculating biases. Utilizing data from 129 participants, we developed equations for C-in based on C-d Ser and C-cre using a linear regression model, and the performance was validated in 68 participants. Findings: The means of C-in and C-d Ser were 66.7 and 55.7 mL/min/1.73 m 2 of body surface area, respectively, in the entire cohort. C-d Ser underestimated C-in with a proportional bias of 22.0% (95% confidence interval, 14.2–29.8%) and a constant bias of -1.24 (-5.78–3.31), whereas the proportional bias was minor to that of C-cre (34.6% [31.1–38.2%] and 2.47 (-1.18–6.13) for proportional and constant bias, respectively). Combination of C-d Ser and C-cre measured C-in with an equation of 0.391 × C-d Ser + 0.418 × C-cre + 3.852, which reduced the proportional bias (6.5% [-0.2–13.1%] and -4.30 [-8.87–0.28] for proportional and constant bias, respectively). In the validation dataset, this equation performed well with median absolute residual of 3.5 [2.3–4.8], and high ratio of agreement (ratios of 30% and 15% different from C-in [P30 and P15 ] of 98.5 [91.4–100] and 89.7 [80.0–95.2], respectively). Interpretation: The smaller proportional bias compared to that of C-cre is an advantage of C-d Ser as a measure of C-in. Combinational measurement of d -serine and creatinine, two endogenous molecules, has the potential to serve as a measure of GFR with precision and minor biases and can support important clinical decisions. Funding: Japan Society for the Promotion of Science (JSPS, grant number 17H04188), Japan Agency of Medical Research and Development (AMED, JP20gm5010001), Osaka Kidney Bank (OKF19-0010), Shiseido Co., Ltd and KAGAMI Inc.